Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 29.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
29.02.SolarMax Technology, Inc. Announces Closing of Initial Public Offering453RIVERSIDE, Calif., Feb. 29, 2024 /PRNewswire/ -- SolarMax Technology, Inc. ("SolarMax" or the "Company") (Nasdaq SMXT), an integrated solar energy company, today announced the closing of its initial...
► Artikel lesen
29.02.Marathon Oil Corporation Announces Key Officer Promotions358HOUSTON, Feb. 29, 2024 /PRNewswire/ -- Marathon Oil Corporation (NYSE: MRO) announced today that Rob L. White has been promoted to Executive Vice President and Chief Financial Officer, effective...
► Artikel lesen
29.02.Carlyle Credit Income Fund Announces First Quarter 2024 Financial Results and Declares 5.63% Increase to Monthly Common Dividends219NEW YORK, Feb. 29, 2024 /PRNewswire/ -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE: CCIF) today announced its financial results for its first quarter ending December...
► Artikel lesen
29.02.Keurig Dr Pepper Announces Sale of up to 100 million Shares of Common Stock by JAB and Repurchase of 35 million Shares by KDP501JAB to Remain Long-Term Anchor Shareholder BURLINGTON, Mass. and FRISCO, Texas, Feb. 29, 2024 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today announced that a subsidiary of JAB Holding...
► Artikel lesen
29.02.Tantech Holdings Ltd.: Tantech Receives NASDAQ Notification Regarding Minimum Bid Requirements412LISHUI, China, Feb. 29, 2024 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that on February 27, 2024, it received a letter from The Nasdaq Stock...
► Artikel lesen
29.02.Betterware de México, S.A.P.I. de C.V.: Betterware De Mexico Announces New Identity For Its Corporate And Commercial Affairs, Naming It Befra388GUADALAJARA, Mexico, Feb. 29, 2024 /PRNewswire/ -- Betterware de México, S.A.P.I. de C.V. (NASDAQ: BWMX), ("BeFra" or the 'Company'"), the leading direct-to-consumer company in Mexico through Betterware...
► Artikel lesen
29.02.NuZee, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)334VISTA, Calif., Feb. 29, 2024 /PRNewswire/ -- NuZee, Inc. (NASDAQ: NUZE) ("NuZee" or the "Company"), a leading coffee co-packing and technology company, today announced that on February 22, 2024...
► Artikel lesen
29.02.Saul Centers, Inc. Reports Fourth Quarter 2023 Earnings198BETHESDA, Md., Feb. 29, 2024 /PRNewswire/ -- Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced its operating results for the quarter ended December 31,...
► Artikel lesen
29.02.B. Riley Financial Launches Review of Strategic Alternatives for Appraisal and Retail, Wholesale & Industrial Solutions Businesses167Company Believes Businesses Not Appropriately Valued by Market, Could Provide Greater Value to Potential Acquirer LOS ANGELES, Feb. 29, 2024 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY)...
► Artikel lesen
29.02.Elanco Animal Health is Executing on Plan to Deliver for Shareholders299Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor GREENFIELD, Ind., Feb. 29, 2024 /PRNewswire/ -- Elanco Animal Health...
► Artikel lesen
29.02.Life360 reports CY 2023 results186SAN FRANCISCO, Feb. 29, 2024 /PRNewswire/ -- San Francisco area-based Life360, Inc. (Life360 or the Company) (ASX: 360) today reported audited financial results for the quarter and year ended December...
► Artikel lesen
29.02.Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results969$251 million of Total revenue in 2023 $139 million in Cell Engineering services revenue, representing 31% growth over 2022 78 new Cell Programs added in 2023, representing 32% growth over 2022 and...
► Artikel lesen
29.02.MasTec, Inc.: MasTec Announces Fourth Quarter and Annual 2023 Financial Results and Provides Initial 2024 Guidance245Record Fourth Quarter and Annual Revenue of $3.3 Billion and $12.0 Billion, Respectively Full Year 2023 Cash Flow from Operations of $687 Million, a 95% Increase Over Full Year 2022 Fourth Quarter...
► Artikel lesen
29.02.Quaker Houghton Announces Fourth Quarter And Full Year 2023 Results233Q4'23 net sales of $467.1 million, net income of $20.2 million and earnings per diluted share of $1.12 Q4'23 non-GAAP net income of $31.9 million and non-GAAP earnings per diluted share of $1.78...
► Artikel lesen
29.02.Diamond Hill Investment Group, Inc. Reports 2023 Financial Results And Declares First Quarter Dividend218COLUMBUS, Ohio, Feb. 29, 2024 /PRNewswire/ -- Diamond Hill Investment Group, Inc. (Nasdaq: DHIL) today reported results for the fourth quarter of 2023 and the year ended December 31, 2023. The...
► Artikel lesen
29.02.Spyre Therapeutics, Inc.: Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update272Announced corporate name change to Spyre Therapeutics; appointment of Cameron Turtle, DPhil, as Chief Executive Officer; and began trading on Nasdaq under the symbol "SYRE" SPY001, an anti-a4ß7 antibody...
► Artikel lesen
29.02.Verra Mobility Announces Fourth Quarter and Full Year 2023 Financial Results198Full year 2023 revenue of $817.3 million Full year 2023 net income of $57.0 million Full year 2023 cash flows from operations of $206.1 million MESA, Ariz., Feb. 29, 2024 /PRNewswire/ -- Verra...
► Artikel lesen
29.02.Biohaven Ltd.: Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments225Driving clinical, regulatory, and operational excellence across five innovative platforms focused on immunology, neuroscience, and oncology: Portfolio targeting large indications including obesity...
► Artikel lesen
29.02.Veeva Systems: Veeva Announces Fourth Quarter and Fiscal Year 2024 Results548Fiscal Year 2024 Total Revenues of $2,363.7M, up 10% Year Over Year;Q4 Total Revenues of $630.6M, up 12% Year Over Year Fiscal Year 2024 Subscription Services Revenues of $1,901.6M, up 10% Year Over...
► Artikel lesen
29.02.PTC Therapeutics, Inc.: PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results265- 34% year-over-year growth in 2023 total revenue - - Global filings of sepiapterin remain on track with first submission of the EU MAA expected in March - - Potential NDA submission for vatiquinone...
► Artikel lesen
Seite:  Weiter >>